logo

VTGN

Vistagen·NASDAQ
--
--(--)
--
--(--)
4.66 / 10
Netural

Financial evaluation shows mixed fundamentals, scoring 4.7/10. Key concerns include a significant year-over-year revenue decline of -54.32%, high days sales outstanding at 313.91, and a neutral interest-coverage ratio of 42.48. While some factors like Revenue-MV and Profit-MV provide partial balance, the overall financial health is compromised, warranting caution. Historical back-tests indicate negative monthly returns for several metrics, reinforcing the tempered outlook.

Fundamental(4.66)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score3/3
Weight18.10%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-54.32
Score1/3
Weight-1.06%
1M Return-0.79%
Days sales outstanding
Value313.91
Score1/3
Weight-1.99%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight14.43%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight14.45%
1M Return8.45%
PB-ROE
Value0.22
Score1/3
Weight17.57%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-54.32
Score1/3
Weight-1.02%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight26.76%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight14.19%
1M Return8.41%
Is VTGN undervalued or overvalued?
  • VTGN scores 4.66/10 on fundamentals and holds a Fair valuation at present. Backed by its -50.48% ROE, -8631.90% net margin, -0.31 P/E ratio, 0.26 P/B ratio, and -159.46% earnings growth, these metrics solidify its Netural investment rating.